NERV - Minerva Neurosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
-
-
0
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
0
Operating Expenses
Research Development
37,303
34,889
30,256
20,440
18,533
Selling General and Administrative
17,964
16,841
10,914
9,751
7,576
Total Operating Expenses
55,267
51,730
41,170
30,191
26,110
Operating Income or Loss
-55,267
-51,730
-41,170
-30,191
-26,110
Interest Expense
4
110
614
1,030
1,053
Total Other Income/Expenses Net
-29
-5
-57
175
-16
Income Before Tax
-53,527
-50,171
-40,899
-31,045
-27,082
Income Tax Expense
-
0
-9,376
-
-
Income from Continuing Operations
-53,527
-50,171
-31,523
-31,045
-27,082
Net Income
-53,527
-50,171
-31,523
-31,045
-27,082
Net Income available to common shareholders
-53,527
-50,171
-31,523
-31,045
-27,082
Reported EPS
Basic
-
-1.29
-0.83
-0.99
-1.16
Diluted
-
-1.29
-0.83
-0.99
-1.16
Weighted average shares outstanding
Basic
-
38,793
37,937
31,514
23,412
Diluted
-
38,793
37,937
31,514
23,412
EBITDA
-
-50,043
-40,274
-29,999
-26,011